Further experimental studies are crucial to validate the functional effects of Kanzonol B on LGI1 in cellular and animal models of epilepsy, particularly those linked to LGI1 dysfunction, and to determine its precise mechanism of action in modulating LGI1-mediated synaptic transmission. Here, LGI1 is linked to epilepsy.